POLMERIC TRANSFECTION REAGENTS TO DELIVER NUCLEIC ACIDS FOR HOST CELL MODIFICATION

CANCER THERAPIES COMPRISING PEPTIDE LOADED CXCR3- AND CCR5-INDUCING DENDRITIC CELLS AND CHEMOKINE MODULATORY AGENTS

AGENT FOR USE IN THE TREATMENT OF GLIOMA

COMPOSITION FOR ALLEVIATING HAIR GRAYING, PROMOTING HAIR GROWTH AND/OR PREVENTING OR ALLEVIATING HAIR LOSS, COMPRISING DOUBLE-STRANDED MIRNA AS ACTIVE INGREDIENT

NANOVESICLES DERIVED FROM CELL MEMBRANE, AND USE THEREOF

NOVEL THERAPEUTIC AGENT FOR SEPTICEMIA, AND A METHOD FOR SCREENING FOR SAME

CATIONIC LIPIDS AND COMPOSITIONS THEREOF

METHOD FOR PREVENTING OR TREATING DENTIN-DENTAL PULP DISEASE OR PERIODONTAL DISEASE, CONTAINING LPAR2 INHIBITOR

LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF

GLUCOKINASE (GCK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (SINA)

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

Biodegradable lipids for the delivery of active agents

Uses of a saponin and method for its isolation

SEQUENTIAL INNATE AND ADAPTIVE IMMUNE MODULATION FOR CANCER TREATMENT

THERAPEUTIC TREATMENT OF TUMORS BY BLOCKING THE HEME SYNTHESIS-EXPORT AXIS

LIPID BILAYER COATED MESOPOROUS SILICA NANOPARTICLES WITH A HIGH LOADING CAPACITY FOR ONE OR MORE ANTICANCER AGENTS

HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL

Methods and Compositions for Managing Vascular Conditions Using miR-483 Mimics and HIF1alpha Pathway Inhibitors

RNAi AGENTS, COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING TRANSTHYRETIN (TTR) ASSOCIATED DISEASES

LIPID-MODIFIED NUCLEIC ACID COMPOUNDS AND METHODS

IMMUNO-ONCOLOGY THERAPEUTIC COMPOSITION USING ADJUVANT INCLUDING LIPOPEPTIDES AND POLY (I:C)

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

METHODS AND COMPOSITIONS FOR TAU REDUCTION GENE THERAPY

BETA-CATENIN (CTNNB1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

COMPOSITIONS AND METHODS FOR PROMOTING THE MINERALIZATION OF BIOLOGICAL TISSUE

COMPOSITIONS AND METHODS TO TRANSFECT, TEST, AND TREAT SKIN CELLS

Methods Of Treating Metabolic Disorders And Cardiovascular Disease With Inhibin Subunit Beta E (INHBE) Inhibitors

SYNTHETIC DNA VECTORS AND METHODS OF USE

METHODS AND COMPOSITIONS FOR TREATING AN ANGIOTENSINOGEN- (AGT-) ASSOCIATED DISORDER

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS

RAAV-BASED COMPOSITIONS AND METHODS

MULTITARGETING RNA COMPOSITIONS

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF CNNM4 IN A CELL

SIRNA TARGETING 17Beta-HYDROXYSTEROID DEHYDROGENASE TYPE 13 AND SIRNA CONJUGATE

ANTIVIRAL NUCLEIC ACID

USE OF MICRORNAS IN THE TREATMENT OF FIBROSIS

COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-beta

STRONG POTENTIATION OF TLR3 AGONISTS EFFECTS USING FXR AGONISTS AS A COMBINED TREATMENT

Nucleic Acid Containing Nanoparticles

DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS

ANTI-CD96 ANTIBODIES AND METHODS OF USE THEREOF

Combination Therapies Comprising C/EBP Alpha saRNA

Treatment Of Type 2 Diabetes With Hepatocyte Nuclear Factor 4 Alpha (HNF4A) Agonists

COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY

METHODS OF DETECTING AND REDUCING CANCER CELL CENTRAL NERVOUS SYSTEM COLONIZATION

ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS

METHODS FOR TREATING GLIOBLASTOMA OR RECURRENT GLIOBLASTOMA UTILIZING A WIRELESS SIGNAL ALONE OR IN COMBINATION WITH ONE OR MORE CANCER DRUGS, AND ASSOCIATED SYSTEMS, APPARATUSES, AND DEVICES

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

Compositions and methods for detecting proteinopathies

METHODS AND COMPOSITIONS FOR DETECTION OF TUMOR DNA

DEOXYRIBONUCLEOSIDE OR DEOXYRIBONUCLEOTIDE HAVING NOVEL ARTIFICIAL BASE APPLICABLE TO SCREENING FOR DNA APTAMER, AND NUCLEIC ACID CONTAINING THE SAME

KETOHEXOKINASE (KHK) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Non-liposomal systems for nucleic acid delivery

DOUBLE-STRANDED SIRNA HAVING PATTERNED CHEMICAL MODIFICATIONS

CATIONIC LIPID

STAUFEN1 AGENTS AND ASSOCIATED METHODS

PEGYLATED LIPID, LIPOSOME MODIFIED BY THE LIPID, PHARMACEUTICAL COMPOSITION CONTAINING THE LIPOSOME, FORMULATION AND APPLICATION THEREOF

THERAPY FOR METASTATIC UROTHELIAL CANCER WITH THE ANTIBODY-DRUG CONJUGATE, SACITUZUMAB GOVITECAN (IMMU-132)

EXTRACELLULAR VESICLES LOADED WITH AT LEAST TWO DIFFERENT NUCLEIC ACIDS

TMEM173 saRNA Compositions and Methods of Use

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF PCSK9

ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

ADJUVANTED MUCOSAL SUBUNIT VACCINES FOR PREVENTING SARS-COV-2 TRANSMISSION AND INFECTION

LIPOSOME COMPOSITIONS AND METHODS OF USE THEREOF

Sequence specific antimicrobials

STING DEPENDENT ADJUVANTS

METHOD OF TREATING FATTY LIVER DISEASE

IN VITRO AND IN VIVO INTRACELLULAR DELIVERY OF SIRNA VIA SELF-ASSEMBLED NANOPIECES

CARBON NANOPARTICLE COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTICS TO SPECIFIC TARGET SITES

RNA SEQUENCE ADAPTATION

Lipid formulations for delivery of therapeutic agents

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

OLIGONUCLEOTIDE FOR INDUCING N-EXON SKIPPING DURING REST MRNA PRECURSOR PROCESSING

Treatment Of Inflammation With Glucocorticoids And Angiopoietin-Like 7 (ANGPTL7) Inhibitors

COMPOSITIONS AND METHODS FOR MODIFYING A PREDETERMINED TARGET NUCLEIC ACID SEQUENCE

PEG LIPIDS AND LIPID NANOPARTICLES

ALPHA-1 ANTITRYPSIN (AAT) RNAI AGENTS, COMPOSITIONS INCLUDING AAT RNAI AGENTS, AND METHODS OF USE

ALLELE SELECTIVE INHIBITION OF MUTANT C9ORF72 FOCI EXPRESSION BY DUPLEX RNAS TARGETING THE EXPANDED HEXANUCLEOTIDE REPEAT

HSD17B13 VARIANTS AND USES THEREOF

ANTI-CTLA4 ANTIBODIES AND METHODS OF MAKING AND USING THE SAME

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF HEARING LOSS

DOSAGE REGIMEN FOR THE TREATMENT OF NASH

TREATMENT FOR AORTOPATHY

METHODS AND COMPOSITIONS FOR CONTROL OF ARTHROPOD PESTS

USE OF MICRORNAS IN THE TREATMENT OF FIBROSIS

RNAI AGENT FOR INHIBITING HBV EXPRESSION AND USE THEREOF

RNAI CONJUGATES AND USES THEREOF

NUCLEIC ACIDS ENCODING HIV NEUTRALIZING ANTIBODIES AND USES THEREOF

COMPOSITION AND METHOD FOR REDUCING OXALATE LEVELS IN PATIENTS RECEIVING MAINTENANCE DIALYSIS

Compositions and methods for delivery of RNA

COMPOSITIONS AND METHODS FOR DELIVERY OF BIOMACROMOLECULE AGENTS

USE OF SODIUM TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] FOR TREATING CANCERS

METHODS FOR PREPARATION OF PLASMID DNA/LIPID PARTICLES WITH DEFINED SIZE FOR IN VITRO AND IN VIVO TRANSFECTION

Advanced Cell-Permeable Peptide Carriers

METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF 2019-nCoV USING siRNAs AGAINST ORF1AB and N-Protein

METHODS AND COMPOSITIONS RELATED TO T-CELL ACTIVITY

NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS

COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION AND GEOGRAPHIC ATROPHY

METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS

METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS IN THE INNER EAR OF ADULT MAMMALS

METHODS AND COMPOSITIONS FOR TREATING CANCERS USING ANTISENSE

TRPC3 AS A THERAPEUTIC TARGET FOR ALZHEIMER’S DISEASE

Novel Replicase Cycling Reaction (RCR) and the Related RdRP-Binding Site Designs Thereof

NANOPARTICLE COMPOSITIONS CONTAINING SUGAR FUNCTIONALIZED NUCLEIC ACID CARRIERS

COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS

COMPOSITIONS AND METHODS FOR IMPROVING IMMUNE SYSTEM FUNCTION

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE

METHOD OF MODULATING CELL PROLIFERATION

MICELLAR NANOPARTICLES AND USES THEREOF

LOCALIZED THERAPY OF LOWER AIRWAYS INFLAMMATORY DISORDERS WITH PROINFLAMMATORY CYTOKINE INHIBITORS

TOXIC RNAi ACTIVE SEED SEQUENCES FOR KILLING CANCER CELLS

FACTOR XII (HAGEMAN FACTOR) (F12), KALLIKREIN B, PLASMA (FLETCHER FACTOR) 1 (KLKB1), AND KININOGEN 1 (KNG1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF

ENGINEERED ANTIBODIES AND USES THEREOF

HYALURONAN IS A DRIVER OF COVID-19 SEVERITY

ROR2 INHIBITORS AND USE THEREOF IN TREATING AND/OR PREVENTING CARTILAGE LOSS

ANTIBODIES BINDING TO GPRC5D

LIPID NANOPARTICLES FOR DELIVERING THERAPEUTICS TO LUNGS

Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells

THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B

PHARMACEUTICAL COMPOSITION CONTAINING DOUBLE-STRANDED RIBONUCLEIC ACID INHIBITING EXPRESSION OF COMPLEMENT C5

MODULATION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) EXPRESSION

Lipids and compositions for the delivery of therapeutics

RNAi APPROACH FOR CROP PEST PROTECTION

ANGIOTENSINOGEN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF

Physiologically active substance carrier

COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING VIRAL INFECTIONS

Oligomers and oligomer conjugates

NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY

OLIGONUCLEOTIDES FOR PMS2 MODULATION

TREATMENT OF HEMOPHILIA WITH FITUSIRAN

RECOMBINANT PROTEIN TARGETING PD-1 AND TGFBETA

TREATMENTS OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)

AMINO ALCOHOL IONIZABLE LIPIDS

Exosome-targeted DNA vaccine

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

METHODS AND COMPOSITIONS FOR WOUND HEALING

SYNERGISTIC INDUCTION OF IMMUNITY AGAINST RNA VIRUSES

Extrahepatic delivery

Albumin Production and Cell Proliferation

Compositions and methods for nanoparticle lyophile forms

SIRNA FOR TREATING HEPATIC FIBROSIS AND DELIVERY PREPARATION THEREOF

CHEMICAL MODIFICATIONS FOR INHIBITING EXPRESSION OF ALDH2

HUMAN ORAL MUCOSA STEM CELL SECRETOME

COMPOSITIONS AND METHODS FOR MODIFYING BACTERIAL GENE EXPRESSION

METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH LPA-TARGETED RNAi CONSTRUCTS

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

METHODS FOR PRODUCTION OF MSC-DERIVED EXOSOMES

SIRNA, MEDICAL COMPOSITIONS, AND METHODS FOR TREATING DIABETES USING THE SAME

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER

METHODS FOR X CHROMOSOME REACTIVATION

IMMUNOTHERAPY FOR THE TREATMENT OF CANCER

LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

Modified short interfering nucleic acid (siNA) molecules and uses thereof

HOMOGENEOUS BETA-1,3-GLUCAN/NUCLEIC ACID COMPLEXES AND USE THEREOF

SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS OF USE OF CRISPR-CAS SYSTEMS IN NUCLEOTIDE REPEAT DISORDERS

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

METHODS AND COMPOSITIONS FOR GENOMIC INTEGRATION

Compositions and methods for delivery of RNA

EXTRACELLULAR VESICLE-ASO CONSTRUCTS TARGETING STAT6

Methods for treating or preventing ophthalmological conditions

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

COMPOUNDS AND METHODS FOR REDUCING IFNAR1 EXPRESSION

COMPOUNDS AND METHODS FOR REDUCING APOE EXPRESSION

Methods of altering bone growth by administration of Sost or Wise antagonist or agonist

Nucleic acid, composition and conjugate containing same, preparation method, and use thereof

COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN CANCERS

RNAI THERAPY FOR HEPATITIS B VIRUS INFECTION

THERAPEUTIC AGENT FOR MALIGNANT MESOTHELIOMA AND METHOD FOR SELECTING PATIENT HAVING MALIGNANT MESOTHELIOMA

Nanostructured Gels Capable of Controlled Release of Encapsulated Agents

MRNA COMBINATION THERAPY FOR THE TREATMENT OF CANCER

RNA AND NUCLEIC ACID CARRIER INCLUDING THE SAME

USE OF PCSK9 INHIBITOR IN PREPARATION OF PRODUCT FOR TREATING MULTIPLE DISEASES

METHODS OF TREATMENT AND DIAGNOSIS OF MULTIPLE MYELOMA PROGRESSION

METHODS FOR INTRACELLULAR DELIVERY AND ENHANCED GENE TARGETING

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

METHODS AND COMPOSITIONS FOR CANCER TREATMENT BY INHIBITION OF FBXO44

Delivery of hydrophobic active agent particles

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

TREATMENT OF CANCER USING A SMAD3 INHIBITOR

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

Amphiregulin gene-specific double-stranded oligonucleotide and composition for preventing and treating fibrosis-related diseases and respiratory diseases, comprising same

Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof

DISCONTINUOUS OLIGONUCLEOTIDE LIGANDS

Lipid nanoparticle compositions and methods for mRNA delivery

VESICLES COMPRISING A PTEN INHIBITOR AND USES OF SAME

HIGH-THROUGHPUT METHODS FOR PREPARING LIPID NANOPARTICLES AND USES THEREOF

Compositions of DNA Molecules, Methods of Making Therefor, and Methods of Use Thereof

Treatment of amyotrophic lateral sclerosis (ALS)

ANTIVIRAL SILENCING RNA MOLECULES, CHEMICALLY MODIFIED ANTIVIRAL SILENCING RNA MOLECULES WITH ENHANCED CELL PENETRATING ABILITIES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND USES THEREOF FOR TREATMENT OF VIRAL INFECTIONS

TARGETING OF LACTATE DEHYDROGENASE C, METHODS OF PREPARING SAME, AND METHODS OF USING SAME IN COMBINATION WITH ANTI-CANCER TREATMENTS

METHODS FOR ENCAPSULATING POLYNUCLEOTIDES INTO REDUCED SIZES OF LIPID NANOPARTICLES AND NOVEL FORMULATION THEREOF

METHODS FOR THE TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MSH3 ACTIVITY

Methods and Compositions for Diabetes Treatment and Beta-Cell Regeneration

METHODS OF TREATMENT AND DIAGNOSTIC OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH INTENSE STRESS

Modified oligonucleotides

CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES

RNAS for complement inhibition

METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINOPATHY AND OTHER OCULAR DISEASES

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

USE OF APE1/REF-1 INHIBITORS FOR TREATMENT OF RETINAL DISEASES

COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL3 EXPRESSION

METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES

MULTIMERIC OLIGONUCLEOTIDES WITH ENHANCED BIOACTIVITY

POLYPEPTIDES

Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents

Lipid nanoparticle compositions and methods for MRNA delivery

Lipid nanoparticle compositions and methods for MRNA delivery

Compositions and methods for treatment of sepsis-related disorders

METHODS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER

FLT3 LIGAND FUSION PROTEINS AND METHODS OF USE

MOTOR NEURON-SPECIFIC EXPRESSION VECTORS

Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)

Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons

USE OF CIRCUTRN IN PREPARATION OF DRUG FOR TREATING HEART FAILURE, RECOMBINANT VECTOR, AND DRUG FOR TREATING HEART FAILURE

COMPOSITIONS FOR FLCN GENE MODULATION AND METHODS THEREOF

ENGINEERED MICROALGAE FEED TO IMPROVE HONEY BEE PATHOGEN RESISTANCE AND NUTRITION

AGENT FOR PREVENTING OR TREATING MUSCULAR DISEASE

NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF CNNM4 IN A CELL

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFLAMMATION

MODULATION OF FACTOR 11 EXPRESSION

Compositions and methods for inhibiting expression of transthyretin

BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

MODIFIED RNA AGENTS WITH REDUCED OFF-TARGET EFFECT

METHODS AND COMPOSITIONS FOR TREATMENT OF APC-DEFICIENT CANCER

RESPIRATORY SYNCYTIAL VIRUS (RSV) POLYANHYDRIDE NANOPARTICLE VACCINE

Use of PIWI-interacting RNA piR-hsa-211106

Lipid formulations for delivery of therapeutic agents

INTERFERON- INDUCING OLIGONUCLEOTIDE DUPLEXES AND METHODS OF USE

ALL-IN-ONE AAV VECTORS FOR TREATING CORONAVIRUS-INDUCED DISEASES

MODULATING IMMUNE RESPONSE

COMPOSITION FOR TREATING OR SENSITIZING INTERFERON BETA RESISTANT CANCER DISEASE COMPRISING CFLIP SIRNA

CONJUGATE OF DOUBLE-STRANDED SIRNA ANALOGUE

A DBAIT MOLECULE IN COMBINATION WITH KRAS INHIBITOR FOR THE TREATMENT OF CANCER

METHODS FOR INCREASING PLATELET COUNT BY INHIBITING BILIVERDIN IXBETA REDUCTASE

ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER

USE OF STAT4 INHIBITORS FOR PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE

Compositions and Methods for Suppressing MSUT2

NANOPARTICLE PHARMACEUTICAL COMPOSITIONS WITH REDUCED NANOPARTICLE SIZE AND IMPROVED POLYDISPERSITY INDEX

RNA INTERFERENCE-INDUCING NUCLEIC ACID COMPRISING 8-OXOGUANINE, MODIFIED NUCLEIC ACID BINDING TO MICRORNA COMPRISING 8-OXOGUANINE, AND USES THEREOF

CIRCULAR RNA COMPOSITIONS AND METHODS

METHODS AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTIOUS DISEASE

Methods of altering bone growth by administration of Sost or Wise antagonist or agonist

LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION

NUCLEIC ACID MOLECULE TARGETING MITF GENE AND USE THEREOF

SIRNA CONJUGATE, DOUBLE-STRANDED SIRNA CONJUGATE, SALT THEREOF AND APPLICATION THEREOF

POLYPEPTIDES DIRECTED AGAINST VIRAL INFECTION AND USES THEREOF

Pharmaceutical composition comprising organoid and anti-inflammatory agent for preventing or treating inflammatory bowel disease

GENETIC MODIFICATION OF MAMMALIAN CELLS TO CONFER RESISTANCE TO CSF1R ANTAGONISTS

AMPHIREGULIN GENE-SPECIFIC DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR PREVENTING AND TREATING FIBROSIS-RELATED DISEASES AND RESPIRATORY DISEASES, COMPRISING SAME

DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR TREATING COVID-19 CONTAINING SAME

Compositions and methods of treating muscle atrophy and myotonic dystrophy

Compositions and methods of treating muscle atrophy and myotonic dystrophy

COMPOSITIONS AND METHODS FOR TREATING VIRUS INFECTION

COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING MICROBIAL INFECTIONS

RIG-I AGONISTS AND METHODS USING SAME

Nucleic acid molecules capable of modulating target gene expression and uses thereof

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER OR OTHER DISEASES

INHIBITION OF CYTOKINE-INDUCED SH2 PROTEIN IN NK CELLS

COMPOSITIONS AND METHODS FOR SILENCING DNAJC15 GENE EXPRESSION

Compositions and methods for dengue virus chimeric constructions in vaccines

ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF

PHARMACEUTICAL COMBINATION AND USE THEREOF

COMBINATION THERAPIES TARGETING MITOCHONDRIAL BIOGENESIS FOR CANCER THERAPY

HETERONUCLEIC ACID CONTAINING MORPHOLINO NUCLEIC ACID

CHANNEL MODULATORS

Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors

COMPOSITIONS AND METHODS FOR SILENCING SCN9A EXPRESSION

Anti-tissue factor antibodies, antibody-drug conjugates, and related methods

Nanotherapy Targeting RHAMM-Positive Tumors

Inhibitors of C5a for the Treatment of Corona Virus Infection

Oral Drug Delivery System and Method for Fabricating Thereof

COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION

EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF DISEASE

SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (SINA) CONJUGATED TO A LIPOPHILIC MOIETY

RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION

Methods and compositions for genomic integration

TARGETING ALPHA3BETA1 INTEGRIN FOR TREATMENT OF CANCER AND OTHER DISEASES

SIRP-GAMMA TARGETED AGENTS FOR USE IN THE TREATMENT OF CANCER

COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING INFECTIONS

POLYMERIC NANOPARTICLES AND DERIVATIVES THEREOF FOR NUCLEIC ACID BINDING AND DELIVERY

CHIMERIC RECEPTOR BINDING PROTEINS RESISTANT TO PROTEOLYTIC DEGRADATION

Amino Acid Mediated Gene Delivery and Its Uses

LIPID MEMBRANE STRUCTURE FOR DELIVERY INTO SIRNA CELL

NOVEL USE OF ASPIRIN COMPOUND IN INCREASING NUCLEIC ACID EXPRESSION

METHODS OF ATTENUATING AN IMMUNE RESPONSE BY INHIBITION OF BFL1

LEUCINE-RICH REPEAT KINASE 2 (LRRK2) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of Use

Composition for preventing or treating keloids or hypertrophic scars

METHODS AND COMPOSITIONS FOR TREATMENT OF ATHEROSCLEROSIS